Invention Grant
- Patent Title: Heterocyclyl-butanamide derivatives
-
Application No.: US15308974Application Date: 2015-04-16
-
Publication No.: US09809598B2Publication Date: 2017-11-07
- Inventor: Hans-Peter Buchstaller , Dieter Dorsch
- Applicant: Merck Patent GmbH
- Applicant Address: DE Darmstadt
- Assignee: MERCK PATENT GMBH
- Current Assignee: MERCK PATENT GMBH
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano, Branigan, P.C.
- Priority: EP14001613 20140507
- International Application: PCT/EP2015/000793 WO 20150416
- International Announcement: WO2015/169421 WO 20151112
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K31/517 ; C07D491/052 ; A61K31/502 ; A61K31/501 ; A61K31/4985 ; A61K31/454 ; C07D413/06 ; C07D401/14 ; C07D491/04 ; C07D495/04 ; C07D413/04 ; C07D401/06 ; C07D471/04 ; A61K31/519

Abstract:
Compounds of the formula I in which W, X and Y have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
Public/Granted literature
- US20170073347A1 HETEROCYCLYL-BUTANAMIDE DERIVATIVES Public/Granted day:2017-03-16
Information query